What Are BPC-157 and TB-500? Sports Recovery Entries
Single peptides related to tissue repair.
Mechanisms and Research Highlights
Section titled “Mechanisms and Research Highlights”Sports injuries heal slowly because three steps get stuck: blood supply, cell migration, and inflammation. The related ingredients map onto these three pathways and can be discussed alone or as blend combinations:
| Bottleneck | Ingredient/blend | What it brings |
|---|---|---|
| Blood supply and local repair signals | BPC-157 | Core ingredient in tendon/gut repair research |
| Cell migration and cytoskeleton | TB-500 | Deep soft tissue, broad migration |
| Inflammatory transcription | KPV | Stubborn inflammation, synovium |
Relation to training: biological interventions cannot replace progressive loading; both need to be assessed in parallel.
BPC-157
Section titled “BPC-157”A gastric-derived pentadecapeptide, with substantial research on microvascular and mucosal repair.
| Attribute | Value |
|---|---|
| Spec code | BA10 / BA5 (legacy BP10) |
| Abbreviation | BPC-157 |
| Specs | 10mg / 5mg (arginate) |
| Mechanism | VEGF upregulation and microvascular angiogenesis; intestinal mucosal tight junctions (Claudin-1); tendon fibroblast migration |
| Scenario | Tendons/ligaments/meniscus; GI ulcers, leaky-gut barrier |
For related mechanisms see TB-500, KPV, BT20, and WOLVERINE22; read side by side to understand the synergy. For the full mechanism description see BPC-157. For the corresponding practical problems see Tendon Recovery and Ligament and Meniscus.
TB-500
Section titled “TB-500”Based on the active-fragment concept of thymosin β4; related to cell migration.
| Attribute | Value |
|---|---|
| Spec code | TB10 / TB5 / TB2 |
| Abbreviation | TB-500 |
| Specs | 10mg / 5mg / 2mg |
| Mechanism | Regulates actin polymerization and the cytoskeleton, driving endothelial cell migration |
| Scenario | Deep muscle strains and tears, fibrosis prevention, soft-tissue protection |
For related mechanisms see BPC-157, BT20, and GLOW70; read side by side to understand the synergy. For the corresponding practical problems see Muscle Strains and Scar Adhesion.
A tripeptide derived from α-MSH; related to NF-κB inhibition.
| Attribute | Value |
|---|---|
| Spec code | KPV10 / KPV5 |
| Abbreviation | KPV |
| Specs | 10mg / 5mg |
| Mechanism | Blocks NF-κB transcription, downregulating IL-1β and TNF-α |
| Scenario | Stubborn inflammation, synovitis, ulcerative colitis |
For related mechanisms see BPC-157 and WOLVERINE22; read side by side to understand the synergy. For the corresponding practical problems see Joint Care.
ARA-290
Section titled “ARA-290”An EPO-derived tissue-protective peptide; related to IRR.
| Attribute | Value |
|---|---|
| Spec code | ARA10 |
| Abbreviation | ARA-290 |
| Specs | 10mg |
| Mechanism | Selectively activates the IRR tissue-protective receptor without stimulating erythropoiesis |
| Scenario | Peripheral nerve repair, small-fiber neuropathy-related pain |
Mechanistically related to Humanin.
A human antimicrobial peptide fragment; membrane disruption and LPS neutralization.
| Attribute | Value |
|---|---|
| Spec code | LL37 |
| Abbreviation | LL-37 |
| Mechanism | Cationic antimicrobial peptide disrupts membranes and neutralizes LPS |
| Scenario | Anti-infection for hard-to-heal wounds, intestinal bacterial overgrowth |
For related mechanisms see KPV and GHK-Cu; read side by side to understand the synergy. For the corresponding practical problems see Scar Adhesion.
Quality and Composition Notes (General)
Section titled “Quality and Composition Notes (General)”| Item | Notes |
|---|---|
| Salt form | e.g. BPC-157 commonly arginate |
| Purity | HPLC ≥ specification (research grade commonly ≥98%) |
| Storage | Protect from light, keep cold and dry; use promptly after reconstitution |
| Blend ratios | Follow the experimental design or product documentation |
For specific batch-number data see the supplier COA.
What Is the Relationship Between BPC-157 and TB-500?
Section titled “What Is the Relationship Between BPC-157 and TB-500?”The mechanisms are complementary: blood supply/local signals vs migration/cytoskeleton; for combinations and scenarios see BT20 and Tendons.
Is There an Anti-Inflammatory Ingredient?
Section titled “Is There an Anti-Inflammatory Ingredient?”KPV is related to NF-κB; see KPV.
Key References
Section titled “Key References”For BPC-157 and TB-500 research indexes see BPC-157 and TB-500; tendon healing animal study PMID: 14554208.
Repair Timing and Route Choice
Section titled “Repair Timing and Route Choice”Choosing among repair-oriented entries is not just about “which ingredient is stronger”, but which phase you are in and which route you use.
Acute Phase versus Repair Phase
Section titled “Acute Phase versus Repair Phase”The acute phase follows specialist principles: immobilization, cold, and clear diagnosis first; ingredients and nutritional support belong to the repair phase. Timeline references are in Ligament and Meniscus and Tendon Injury.
Topical, Oral, and Injected Routes
Section titled “Topical, Oral, and Injected Routes”Route determines bioavailability and the risk structure: sterility and purity of injectable products are hard constraints (testing conventions in How to Read a COA), and oral and topical routes sit at different evidence levels (see Bioavailability). The overall recovery division of labor in sports contexts is in Muscle Recovery.
This page is for research and teaching reference only and does not constitute medical advice or dosing guidance; acute injuries require prompt medical care, and any injectable product should be used under a physician’s guidance.
Related Reading
Section titled “Related Reading”Safety Boundaries and Limitations
Section titled “Safety Boundaries and Limitations”Repair research is mainly animal and mechanistic. The quality of injectable products determines infection and immune risk. Acute injuries still require specialist care principles.
Practical workflow and quality control: before using or comparing an ingredient, see reconstitution, storage, COA, and administration routes; operating standards in Peptide Basics.